Skip to main content
Go to the U of M home page
  • One Stop
  • MyU

Minnesota Law Review

Menu
  • Archives
    • Subscriptions
  • Headnotes
    • Submissions
  • De Novo
  • About
    • Alumni
    • Current Masthead
    • Membership
  • Banquet
  • Symposium
    • Symposia Archive
      • 2024-25 Symposium
  • Submissions

Vol. 102: Iss. 6, 2018

A Prescription for Pharmaceutical's Future: Balancing Industry and Consumer Concerns in Pharmaceutical Drug Development

What Makes Ensuring Access to Affordable Prescription Drugs the Hardest Problem in Health Policy?

Delinking Reimbursement

Dangerous Times: The FDA's Role in Information Production, Past and Future

Regulatory Silence at the FDA

Drug Approval in a Learning Health System

The Morality of Compulsory Licensing as an Access to Medicines Tool

I Get by with a Little Help from My 750-Dollar-Per-Tablet Friends: A Model Act for States to Prevent Dramatic Pharmaceutical Price Increases

Minnesota Law Review
229 19th Ave. South
Minneapolis, MN 55455

Tel: (612) 625-9330
Fax: (612) 624-5400
[email protected]

Group Footer Menu

  • Archives
  • Headnotes
  • De Novo

Footer Menus

  • Law Journals
  • Minnesota Law Review
  • Minnesota Journal of Law & Inequality
  • Minnesota Journal of International Law
  • Minnesota Journal of Law, Science and Technology
  • Constitutional Commentary
  • University of Minnesota Law School
  • UMN Publishing Services
  • Log In

For Students, Faculty, and Staff

  • One Stop
  • MyU
©2026 Regents of the University of Minnesota. All rights reserved. The University of Minnesota is an equal opportunity educator and employer. Privacy Statement Report Web Accessibility Issues
  • Archives
    • Subscriptions
  • Headnotes
    • Submissions
  • De Novo
  • About
    • Alumni
    • Current Masthead
    • Membership
  • Banquet
  • Symposium
    • Symposia Archive
      • 2024-25 Symposium
  • Submissions